STPharma

STPharma

Anderlecht ·KBO/BCE: BE 0797.679.993

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-10-2025	31-05-2026	13-04-2026	48 d early	2026-00078014
31-10-2024	31-05-2025	09-05-2025	22 d early	2025-00093631

Metric	This company	Sector median	Position in the sector
Solvency	85.7%	42.6%	better than 95% of 185 sector peers
Net result	€635	€159k	better than 19% of 185 sector peers
Equity	€27k	€1.19M	better than 10% of 185 sector peers
Gross operating margin	€3k	€188k	better than 13% of 99 sector peers
Total assets	€31k	€3.26M	better than 5% of 185 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€31k
Fixed assets	21/28	€5k
Intangible fixed assets	21	€5k
Current assets	29/58	€26k
Stocks & contracts in progress	3	€2k
Amounts receivable within one year	40/41	€9k
Cash & bank	54/58	€15k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€31k
Equity	10/15	€27k
Contributions / capital	10/11	€25k
Accumulated profits (losses)	14	€2k
Amounts payable	17/49	€4k
Amounts payable within one year	42/48	€4k
Trade debts payable within one year	44	€4k
Income statement
Gross operating margin	9900	€3k
Operating result	9901	€816
Financial income	75	€13
Financial charges	65	€158
Result before taxes	9903	€672
Income taxes	67/77	€37
Net result for the period	9904	€635
Result to be appropriated	9905	€635

Summary